Dendritic cells at the osteo-immune interface: Implications for inflammation-induced bone loss
Dendritic cells at the osteo-immune interface: Implications for inflammation-induced bone loss
复制标题
DOI:
10.1359/jbmr.070314
复制
发表时间:
2007-06-01
影响因子:
6.2
通讯作者:
Teng, Yen-Tung A.
中科院分区:
文献类型:
--
作者:
Alnaeeli, Mawadda;Park, Jaekweon;Teng, Yen-Tung A.
Within the past decade, the critical roles of T cells and T cell-mediated immunity in inflammation-induced osteoclastogenesis and subsequent bone loss have been extensively studied, thereby establishing the new paradigm of osteoimmunology. Therefore, dendritic cells (DCs), the most potent antigen-presenting cells, responsible for activation of naive T cells and orchestration of the immune response, became critically situated at the osteo-immune interface. Today, emerging new evidence suggests that DC may be directly involved in inflammation-induced osteoclastogenesis and bone loss, by acting as osteoclast (OC) precursors that can further develop into DC-derived OCs (DDOC) under inflammatory conditions. These findings have tremendous implications, because in addition to DC's important roles in regulating innate and adaptive immunity, a direct contribution by these cells to inflammation-induced bone loss may provide a promising therapeutic target not only for controlling inflammation but also for modulating bone destruction.